Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00239993 · ClinicalTrials.gov registry record · Phase 4

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

A Phase 4 study, sponsored by Teva Neuroscience.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target

NCT00239993: Completed Phase 4 study, sponsored by Teva Neuroscience.

NCT00239993 is a Phase 4 study that has completed, run by Teva Neuroscience. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00239993, a Phase 4 study, has completed, sponsored by Teva Neuroscience.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target

Study Summary

This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

Interventions

  • DRUG glatiramer acetate
  • PROCEDURE Warm compress prior to injection of glatiramer acetate

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2005-08
Est. Completion 2006-02
Phase Phase 4
Teva Neuroscience

3 total trials

What the finished NCT00239993 record still lists

NCT00239993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which glatiramer acetate is the first listed.

NCT00239993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00239993 about?

NCT00239993 is a clinical study titled "A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®". This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

What is the current status of trial NCT00239993?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2005-08. Estimated completion is 2006-02.

What interventions are being tested in trial NCT00239993?

The interventions under investigation include: glatiramer acetate (DRUG), Warm compress prior to injection of glatiramer acetate (PROCEDURE).

Who is sponsoring clinical trial NCT00239993?

This trial is sponsored by Teva Neuroscience, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00239993's enrollment target sits among peer trials

50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00239993, the US trial registry maintained by the National Library of Medicine. NCT00239993 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.